Nitrendipin-Ratiopharm (Nitrendipine)

Nitrendipine, the active ingredient in Nitrendipin-Ratiopharm, is a calcium channel blocker presented as an oral tablet for oral use. It is indicated for the management of hypertension in adult patients, helping to lower elevated blood pressure by relaxing vascular smooth muscle.

GNH USA supplies Nitrendipin-Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards.

Nitrendipin-Ratiopharm is a calcium channel blocker used in the treatment of hypertension and related blood‑pressure disorders. - Hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension. - Essential hypertension: assists in achieving target blood‑pressure goals as part of a therapeutic regimen. - Isolated systolic hypertension: improves control of elevated systolic pressure, especially in older adults.

Nitrendipin-Ratiopharm may cause a range of adverse reactions. Patients should be aware of both frequent and less common events.

Common Side Effects: - Headache: mild to moderate pain often occurring shortly after initiation. - Flushing: transient warmth and redness of the skin. - Peripheral edema: swelling of the ankles or lower legs. - Dizziness: sensation of light‑headedness, especially when standing quickly.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Hepatic dysfunction: abnormal liver enzyme elevations or hepatitis. - Allergic reactions: rash, pruritus, or anaphylaxis in susceptible individuals.

Before prescribing Nitrendipin-Ratiopharm, clinicians should consider several safety measures. - Blood pressure monitoring: regularly assess to avoid excessive hypotension. - Hepatic impairment: use with caution and adjust dose if liver function is compromised. - Concomitant antihypertensives: evaluate for additive blood‑pressure‑lowering effects. - Orthostatic dizziness: advise patients to rise slowly from seated or lying positions. - Discontinuation: avoid abrupt cessation; taper if long‑term therapy is required. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nitrendipin-Ratiopharm can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase plasma levels and risk of toxicity. - Other calcium‑channel blockers: additive vasodilatory effect can cause severe hypotension. - Grapefruit juice: can markedly raise drug concentrations.

Moderate Interactions (Monitor Closely):\n- CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce efficacy. - Diuretics: may enhance antihypertensive effect, requiring dose adjustment. - Beta‑blockers: combined use may increase risk of bradycardia and hypotension.